Antihypertensive therapy must be tailored to the individual in order to achieve blood pressure goals and reduce cardiovascular risk

Author： Adis International Limited

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.1, 2007-01, pp. : 7-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olmesartan Medoxomil-Based Antihypertensive Therapy Evaluated by Ambulatory Blood Pressure Monitoring: Efficacy in High-Risk Patient Subgroups

By Chrysant Steven G.

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 6, 2012-12 ,pp. : 375-389

Adis International

Access to resources Recommend Favorite

Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals

By Brunner Hans R.

Clinical Drug Investigation, Vol. 26, Iss. 4, 2006-01 ,pp. : 185-193

Adis International

Access to resources Recommend Favorite

Improving blood pressure control rates by optimizing combination antihypertensive therapy

By Epstein Benjamin J

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2011-2026

Informa Healthcare

Access to resources Recommend Favorite

Antihypertensive Therapy and Cancer Risk

By Felmeden D.C. Lip G.Y.H.

Drug Safety, Vol. 24, Iss. 10, 2001-01 ,pp. : 727-739

Adis International

Access to resources Recommend Favorite

Relationship between the Frequency of Blood Pressure Self-Measurement and Blood Pressure Reduction with Antihypertensive Therapy: Results of the OLMETEL (OLMEsartan TELemonitoring Blood Pressure) Study

By Ewald Silke

Clinical Drug Investigation, Vol. 26, Iss. 8, 2006-01 ,pp. : 439-446

Adis International

Access to resources Recommend Favorite